Manufacturer record
Bengal Chemicals & Pharmaceuticals Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
13 batches manufactured by Bengal Chemicals & Pharmaceuticals Ltd (West Bengal) were declared Not of Standard Quality between October 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
13 records linked to Bengal Chemicals & Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Omeprazole Gastro-resistant Capsules IP 20 mg | GC108503Mfg 2025-03 · Exp 2027-02 | The sample does not conform to IP standards with respect to the test for Dissolution.Dissolution | DTL, ThrissurState lab | Jul 2026 |
| Calcium and Vitamin D3 Tablets IP (500mg+250 IU) (Calcium 500mg & Vitamin D3 250 IU) | T572514Mfg 2025-02 · Exp 2026-07 | This particular batch of sample fails the test 'Dissolution' as per IP.Dissolution | DTL ThrissurState lab | Nov 2025 |
| Calcium and Vitamin D3 Tablets IP (500mg+250 IU) | T572513Mfg 2025-02 · Exp 2026-07 | The sample does not conform to claim as per IP 2022 in respect to the Test of Dissolution of CalciumDissolution | RDTL,ChandigarhCDSCO lab | Nov 2025 |
| Cefuroxime Axetil Tablets IP 500 mg | 4617001Mfg 2024-05 · Exp 2026-04 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2025 |
| Aceclofenac Tablets IP 100 mg | T042304Mfg 2023-11 · Exp 2025-04 | Related substances and Assay of AceclofenacAssay | CDTL MumbaiCDSCO lab | Jan 2025 |
| Cefotaxime Sodium Injection IP 1 g | DP24029Mfg 2024-04 · Exp 2026-03 | Test of Clarity of solution, Particulate matterParticulate matter | CDL KolkataCDSCO lab | Dec 2024 |
| Calcium And Vitamin D3 Tablets IP | BCV-X01Mfg 2024-04 · Exp 2025-09 | Uniformity of Content of Vitamin D3Uniformity of weight/content | CDL KolkataCDSCO lab | Nov 2024 |
| POVIDONE IODINE SOLUTION IP 10% W/V | 2103001Mfg 2022-04 · Exp 2023-09 | pH and AssayAssay | RDTL ChandigarhCDSCO lab | Sep 2022 |
| CefiximeTablets I.P. 100 mg | 8513007Mfg 2018-11 · Exp 2020-10 | Description, Dissolution & AssayAssay | CDL KolkataCDSCO lab | Sep 2020 |
| Diclofenac Sodium Tablets I.P. | DF-R008Mfg 2019-02 · Exp 2021-01 | DisintegrationDisintegration | CDL KolkataCDSCO lab | Jan 2020 |
| Amlodipine Tablets IP 5mg | CHT-9124Mfg 2019-03 · Exp 2021-02 | AssayAssay | CDL ChennaiCDSCO lab | Nov 2019 |
| Paracetamol Tablets I.P. | 821481298Mfg 2019-03 · Exp 2021-02 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2019 |
| Paracetamol Tablet I.P. | 821481296Mfg 2019-03 · Exp 2021-02 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.